Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant B Cell Signaling in Autoimmune Diseases. | Cells | 2022 | 36359789 | PubTator, text mining | PubMed |
| Cell-Free DNA in the Pathogenesis and Therapy of Non-Infectious Inflammations and Tumors. | Biomedicines | 2022 | 36359370 | PubTator, text mining | PubMed |
| Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting. | Biomedicines | 2022 | 36359340 | PubTator, text mining | PubMed |
| A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside. | Biomedicines | 2022 | 36359220 | PubTator, text mining | PubMed |
| Attenuation of Palmitic Acid-Induced Intestinal Epithelial Barrier Dysfunction by 6-Shogaol in Caco-2 Cells: The Role of MiR-216a-5p/TLR4/NF-κB Axis. | Metabolites | 2022 | 36355111 | PubTator, text mining | PubMed |
| Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. | MedComm (2020) | 2022 | 36349142 | PubTator, text mining | PubMed |
| IL-33/ST2 immunobiology in coronary artery disease: A systematic review and meta-analysis. | Front Cardiovasc Med | 2022 | 36337880 | PubTator, text mining | PubMed |
| Medicinal Chemistry of Pyrazolopyrimidine Scaffolds Substituted with Different Heterocyclic Nuclei. | Curr Pharm Des | 2022 | 36330628 | PubTator, text mining | PubMed |
| Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells. | Arch Toxicol | 2022 | 36326898 | PubTator, text mining | PubMed |
| Major pathways involved in macrophage polarization in cancer. | Front Immunol | 2022 | 36325334 | PubTator, text mining | PubMed |
| Chronic inflammation, cancer development and immunotherapy. | Front Pharmacol | 2022 | 36313280 | PubTator, text mining | PubMed |
| Lessons learned from immunological characterization of nanomaterials at the Nanotechnology Characterization Laboratory. | Front Immunol | 2022 | 36304452 | PubTator, text mining | PubMed |
| Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components. | Front Mol Biosci | 2022 | 36299300 | PubTator, text mining | PubMed |
| Foot-and-Mouth Disease Virus: Molecular Interplays with IFN Response and the Importance of the Model. | Viruses | 2022 | 36298684 | PubTator, text mining | PubMed |
| Incorporation of Suppression of Tumorigenicity 2 into Random Survival Forests for Enhancing Prediction of Short-Term Prognosis in Community-ACQUIRED Pneumonia. | J Clin Med | 2022 | 36294336 | PubTator, text mining | PubMed |
| TLR4-Pathway-Associated Biomarkers in Subarachnoid Hemorrhage (SAH): Potential Targets for Future Anti-Inflammatory Therapies. | Int J Mol Sci | 2022 | 36293468 | PubTator, text mining | PubMed |
| Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström Macroglobulinemia. | Cells | 2022 | 36291152 | PubTator, text mining | PubMed |
| Ubiquitin proteasome system in immune regulation and therapeutics. | Curr Opin Pharmacol | 2022 | 36288660 | PubTator, text mining | PubMed |
| Depicting the Implication of miR-378a in Cancers. | Technol Cancer Res Treat | 2022 | 36285472 | PubTator, text mining | PubMed |
| ERK1/2 in immune signalling. | Biochem Soc Trans | 2022 | 36281999 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=33